tradingkey.logo
搜索
市场行情
自选
新闻
分析
交易工具
选股器
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
搜索

Emergent BioSolutions Inc

EBS
添加自选
6.800USD
-0.220-3.13%
收盘 09-18 16:00（美东）
347.81M总市值
亏损市盈率 TTM
盘后交易 19:00 (美东)6.800USD-0.030-0.44%

Emergent BioSolutions Inc

6.800
-0.220-3.13%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

概览

新闻分析

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

EBS 财务数据

通过专为投资者打造的一站式数据看板，全面查看 Emergent BioSolutions Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值
347.81M
股息TTM
0.00
市盈率 TTM
-49.93
每股收益TTM
-0.14
营业收入
742.90M
净利润
-190.60M
净资产收益率
-1.60%
总资产收益率
-0.63%

Emergent BioSolutions Inc 财报日历

最新发布
8月 6, 2026
每股收益 / 预测值
-3.49/0.11
营业收入 / 预测值
234.30M/177.50M

财务报表摘要

单季报
单季报+年报
单季报
年报
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-1477.35%-3.49
-89.52%0.13
-80.78%-1.04
-55.48%0.96
95.89%-0.22
625.02%1.25
39.22%-0.58
142.52%2.16
-4.43%-5.38
104.65%0.17
37.58%-0.95
---5.08
---5.15
---3.71
---1.52
----
----
----
----
----
营业收入
66.29%234.30M
-29.75%156.10M
-23.63%148.70M
-21.34%231.10M
-44.68%140.90M
-26.03%222.20M
-29.61%194.70M
8.61%293.80M
-24.62%254.70M
82.84%300.40M
-15.49%276.60M
12.76%270.50M
39.23%337.90M
-46.57%164.30M
-53.52%327.30M
-27.08%239.90M
-38.94%242.70M
-10.35%307.50M
20.77%704.10M
-14.59%329.00M
净利润
-1401.67%-180.20M
-90.00%6.80M
-74.44%-54.60M
-55.40%51.20M
95.76%-12.00M
655.56%68.00M
36.77%-31.30M
143.58%114.80M
-8.34%-283.10M
104.83%9.00M
34.70%-49.50M
-202.41%-263.40M
-363.30%-261.30M
-4932.43%-186.20M
-142.61%-75.80M
-166.36%-87.10M
-1326.09%-56.40M
-105.31%-3.70M
-4.05%177.90M
-182.78%-32.70M
利润率
-803.05%-76.91%
-85.77%4.36%
-128.40%-36.72%
-43.30%22.15%
92.34%-8.52%
921.46%30.60%
10.17%-16.08%
140.13%39.07%
-43.73%-111.15%
102.64%3.00%
22.73%-17.90%
---97.38%
---77.33%
---113.33%
---23.16%
----
----
----
----
----
毛利率
11.05%58.56%
-11.06%53.88%
8.91%42.91%
7.68%62.74%
424.42%52.73%
16.80%60.58%
19.09%39.39%
68.22%58.27%
-137.29%-16.25%
647.48%51.86%
-0.21%33.08%
--34.64%
--43.59%
--6.94%
--33.15%
----
----
----
----
----
资产负债率
10.55%52.10%
-6.94%43.44%
-9.15%43.39%
1.23%45.39%
-17.28%47.12%
-7.06%46.68%
1.22%47.76%
-1.51%44.84%
37.42%56.97%
5.95%50.23%
6.27%47.18%
--45.52%
--41.45%
--47.41%
--44.40%
----
----
----
----
----
利润表
营业收入
66.29%234.30M
-29.75%156.10M
-23.63%148.70M
-21.34%231.10M
-44.68%140.90M
-26.03%222.20M
-29.61%194.70M
8.61%293.80M
-24.62%254.70M
82.84%300.40M
-15.49%276.60M
12.76%270.50M
39.23%337.90M
-46.57%164.30M
-53.52%327.30M
-27.08%239.90M
-38.94%242.70M
-10.35%307.50M
20.77%704.10M
-14.59%329.00M
营业利润
2351.85%66.20M
-79.49%10.50M
-37.37%-13.60M
-7.20%65.70M
101.70%2.70M
30.28%51.20M
77.70%-9.90M
2066.67%70.80M
-1262.04%-159.20M
128.50%39.30M
20.29%-44.40M
92.05%-3.60M
119.03%13.70M
-2254.69%-137.90M
-118.09%-55.70M
-30.55%-45.30M
-596.55%-72.00M
-93.29%6.40M
17.70%307.90M
-133.33%-34.70M
净利润
-1401.67%-180.20M
-90.00%6.80M
-74.44%-54.60M
-55.40%51.20M
95.76%-12.00M
655.56%68.00M
36.77%-31.30M
143.58%114.80M
-8.34%-283.10M
104.83%9.00M
34.70%-49.50M
-202.41%-263.40M
-363.30%-261.30M
-4932.43%-186.20M
-142.61%-75.80M
-166.36%-87.10M
-1326.09%-56.40M
-105.31%-3.70M
-4.05%177.90M
-182.78%-32.70M
资产负债表
流动资产
-7.44%666.00M
-9.79%637.60M
10.66%662.50M
18.97%786.90M
9.93%719.50M
3.58%706.80M
-11.89%598.70M
-8.24%661.40M
-15.84%654.50M
-44.13%682.40M
-43.86%679.50M
-35.56%720.80M
-28.27%777.70M
11.00%1.22B
-4.85%1.21B
0.63%1.12B
-6.70%1.08B
-6.84%1.10B
6.37%1.27B
15.93%1.11B
流动负债总额
-3.38%122.80M
32.89%148.70M
-18.60%132.20M
-40.63%136.50M
-79.49%127.10M
-82.24%111.90M
-75.07%162.40M
-65.38%229.90M
-10.60%619.70M
-48.16%630.20M
-47.00%651.30M
147.39%664.00M
150.52%693.20M
387.84%1.22B
228.76%1.23B
-26.55%268.40M
-26.76%276.70M
-32.69%249.20M
-2.78%373.80M
22.08%365.40M
总资产
-21.19%1.12B
-7.41%1.32B
-5.12%1.32B
-1.14%1.46B
-6.37%1.42B
-20.93%1.43B
-23.78%1.39B
-21.94%1.48B
-30.54%1.51B
-38.86%1.80B
-42.42%1.82B
-34.91%1.89B
-20.35%2.18B
6.09%2.95B
7.01%3.17B
1.43%2.91B
-6.17%2.74B
-4.13%2.78B
2.63%2.96B
9.60%2.87B
总负债
-11.98%775.40M
-8.71%797.30M
-12.23%796.00M
-9.38%878.50M
-21.85%880.90M
-23.37%873.40M
-22.74%906.90M
-18.94%969.40M
-7.80%1.13B
-34.77%1.14B
-34.00%1.17B
-18.04%1.20B
0.02%1.22B
44.98%1.75B
32.73%1.78B
8.51%1.46B
-10.89%1.22B
-12.50%1.21B
-6.70%1.34B
-1.47%1.34B
总权益
-36.33%341.40M
-5.36%523.10M
8.24%522.60M
14.58%582.50M
38.80%536.20M
-16.75%552.70M
-25.64%482.80M
-27.08%508.40M
-59.60%386.30M
-44.79%663.90M
-53.21%649.30M
-51.89%697.20M
-36.80%956.30M
-23.66%1.20B
-14.29%1.39B
-4.82%1.45B
-1.98%1.51B
3.45%1.58B
11.89%1.62B
21.67%1.52B
现金流量表
经营净额
-47.27%56.10M
-201.79%-33.80M
197.25%77.70M
-101.50%-2.30M
124.00%106.40M
82.11%-11.20M
-348.91%-79.90M
156.17%153.70M
141.52%47.50M
65.98%-62.60M
-65.41%32.10M
181.08%60.00M
-633.33%-114.40M
-393.30%-184.00M
-71.79%92.80M
-543.11%-74.00M
47.47%-15.60M
-831.37%-37.30M
34.23%329.00M
-84.13%16.70M
投资净额
-404.07%-52.30M
-104.03%-2.40M
-113.64%-3.90M
-103.04%-3.40M
473.91%17.20M
650.93%59.50M
350.88%28.60M
692.59%112.00M
-101.79%-4.60M
28.48%-10.80M
74.89%-11.40M
93.04%-18.90M
902.80%257.70M
53.11%-15.10M
2.78%-45.40M
-392.03%-271.60M
52.09%-32.10M
42.60%-32.20M
-29.72%-46.70M
-20.79%-55.20M
融资净额
-281.25%-24.40M
-2750.00%-11.40M
-22880.00%-113.90M
91.18%-15.90M
87.43%-6.40M
-100.98%-400.00K
-89.36%500.00K
-319.30%-180.30M
89.55%-50.90M
487.62%40.70M
-98.67%4.70M
-118.75%-43.00M
-1485.99%-486.90M
85.11%-10.50M
421.00%353.10M
4686.00%229.30M
-707.89%-30.70M
-217.57%-70.50M
-4682.61%-110.00M
-105.74%-5.00M

营业收入

业务

报告期:
暂无数据

地区

报告期:
暂无数据

常见问题

Emergent BioSolutions Inc的总收入是多少？

根据Emergent BioSolutions Inc的FY2025财报，总收入达到了742.90M（同比变化1.04B）。

Emergent BioSolutions Inc的流动资产是多少？

根据Emergent BioSolutions Inc的FY2025财报，流动资产为662.50M（同比变化10.66）。

Emergent BioSolutions Inc的总资产是多少？

根据Emergent BioSolutions Inc的FY2025财报，Emergent BioSolutions Inc的总资产为1.32B（同比变化-5.12）。

Emergent BioSolutions Inc的总负债是多少？

根据Emergent BioSolutions Inc的FY2025财报，Emergent BioSolutions Inc的总负债为796.00M（同比变化-12.23）。

Emergent BioSolutions Inc的总权益是多少？

根据Emergent BioSolutions Inc的FY2025财报，Emergent BioSolutions Inc的总权益为522.60M（同比变化8.24）。

Emergent BioSolutions Inc的净营业收入是多少？

根据Emergent BioSolutions Inc的FY2025财报，Emergent BioSolutions Inc的净营业收入为114.40M（同比变化293.90）。

Emergent BioSolutions Inc的净投资是多少？

根据Emergent BioSolutions Inc的FY2025财报，Emergent BioSolutions Inc的净投资为69.40M（同比变化-44.57）。

Emergent BioSolutions Inc的净融资是多少？

根据Emergent BioSolutions Inc的FY2025财报，Emergent BioSolutions Inc的净融资为-136.60M（同比变化28.11）。

Emergent BioSolutions Inc的每股收益（EPS）是多少？

根据Emergent BioSolutions Inc的FY2025财报，每股收益（EPS）为0.98（同比变化127.34）。

Emergent BioSolutions Inc的净利润是多少？

根据Emergent BioSolutions Inc的FY2025财报，净利润为52.60M（同比变化127.60）。

Emergent BioSolutions Inc的净利润率是多少？

根据Emergent BioSolutions Inc的FY2025财报，净利润率为7.08（同比变化138.77）。

Emergent BioSolutions Inc的毛利率是多少？

根据Emergent BioSolutions Inc的FY2025财报，毛利率为56.09（同比变化61.57）。

Emergent BioSolutions Inc的债务与资产比率是多少？

根据Emergent BioSolutions Inc的FY2025财报，债务与资产比率为43.39（同比变化-9.15）。

Emergent BioSolutions Inc的股东权益回报率（ROE）是多少？

根据Emergent BioSolutions Inc的FY2025财报，股东权益回报率（ROE）为10.46（同比变化131.07）。

Emergent BioSolutions Inc的资产回报率（ROA）是多少？

根据Emergent BioSolutions Inc的FY2025财报，资产回报率（ROA）为3.88（同比变化132.74）。

Emergent BioSolutions Inc的营业利润是多少？

根据Emergent BioSolutions Inc的FY2025财报，营业利润为114.40M（同比变化293.90）。
tradingkey.logo
风险提示：我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐，且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险，包括可能损失投资的本金，且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告，并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
一般使用条款
隐私政策
Cookie政策